Metastatic Digestive System Neuroendocrine Tumor G1
Oncology
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Cabozantinib | Royalty Pharma plc (RPRX) |
Phase 2(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Metastatic Digestive System Neuroendocrine Tumor G1?
BioSniper tracks 2 drugs in development for Metastatic Digestive System Neuroendocrine Tumor G1 across 1 company.
How many clinical trials target Metastatic Digestive System Neuroendocrine Tumor G1?
There are 1 clinical trial targeting Metastatic Digestive System Neuroendocrine Tumor G1 tracked by BioSniper.
Deep-dive into Metastatic Digestive System Neuroendocrine Tumor G1
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis